Source: Annual Congress 2005 - COPD: clinical physiology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Baraldo, E. Bazzan, M. E. Zanin, G. Turato, B. Beghé, K. Dimakou, S. Garbisa, P. Maestrelli, A. Papi, L. Fabbri, R. Zuin, M. Saetta (Padova, Ferrara, Modena, Italy). Increased expression of MMP-2 in COPD. Eur Respir J 2005; 26: Suppl. 49, 2343

Member's Comments

No comment yet.

Related content which might interest you: Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes? Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 MMP-2 expression in lung periphery is related to COPD progression Source: Eur Respir J 2006; 28: Suppl. 50, 550s Year: 2006 Increased CTGF expression of circulating fibrocytes in asthmatic patients with severe OSA - the role of HIF-1a and HDAC7 Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Increased gelatinase and collagenase activity in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 454s Year: 2004 Decreased expression of VEGFR-2 mRNA in pulmonary vessels of COPD patients Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009 Serum levels of TIMP-1 and TIMP-2 are elevated in patients with pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003 Increased concentration of matrix metalloproteinase-9 in serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005 Genes affecting mRNA stability and metalloproteinase inhibitor RECK are down-regulated in patients with COPD Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013 Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Reduced expression of CD44 on lung macrophages from patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 MMP-9 and TIMP-1 expression in acute lung injury rats with diabetes Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004 Decrease in circulating monocyte metalloproteinase-9 content with increasing severity of pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 5s Year: 2002 Circulating matrix metalloproteinase-9 (MMP-9) is associated with the extension of lung disease in patients with active tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004 The influence of steroidotherapy in COPD exacerbation on matrix metalloproteinase MMP-9 level in BAL, induced sputum and serum Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Increased levels of osteopontin in sputum supernatant in patients with COPD Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Relationship between MMP-9 and TIMP-1 induced sputum concentration and the stage of chronic obstructive pulmonary disease‘s (COPD) Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008